Cellectis S.A.
CLLS
$3.24
-$0.08-2.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.07% | 2.00% | -544.41% | 102.55% | 6.07% |
| Total Depreciation and Amortization | -12.06% | -8.03% | -23.57% | 6.17% | 6.11% |
| Total Amortization of Deferred Charges | -- | -- | 61.87% | -- | -- |
| Total Other Non-Cash Items | -90.19% | -138.46% | 171.67% | -41.02% | 76.47% |
| Change in Net Operating Assets | 108.93% | 105.45% | -126.07% | -350.74% | -120.11% |
| Cash from Operations | -38.55% | 10.20% | -21,942.55% | 73.05% | -119.76% |
| Capital Expenditure | 17.05% | 32.91% | 12.91% | -51.99% | 70.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 136.18% | -227.76% | 242.33% | -109.78% | 50.27% |
| Cash from Investing | 135.50% | -245.99% | 234.75% | -115.41% | 50.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 18.05% | -22.85% | -8.87% | -0.42% | 0.71% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 56.48% | 39.74% | 49.07% | 34.98% | -19.14% |
| Cash from Financing | 23.86% | -19.80% | -241.54% | -1.00% | -105.44% |
| Foreign Exchange rate Adjustments | 19.28% | -115.37% | 165.21% | 176.15% | -129.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -150.00% | 150.00% | -- |
| Net Change in Cash | 101.10% | -70.94% | 158.66% | -175.32% | -360.16% |